{"id":8824,"date":"2026-09-01T08:44:13","date_gmt":"2026-09-01T08:44:13","guid":{"rendered":"https:\/\/www.vanguardlifesciences.co.uk\/?p=8824"},"modified":"2026-09-01T08:44:32","modified_gmt":"2026-09-01T08:44:32","slug":"vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer","status":"publish","type":"post","link":"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","title":{"rendered":"Vanguard Life Sciences wita Rebecc\u0119 Lythe na stanowisku Dyrektora Generalnego Grupy"},"content":{"rendered":"
\"\"<\/figure>\n

Rebecca do\u0142\u0105cza do nas w ekscytuj\u0105cym momencie rozwoju Vanguard Life Sciences, poniewa\u017c nadal wykorzystujemy do\u015bwiadczenie Grupy w dostarczaniu z\u0142o\u017conej infrastruktury w \u015bci\u015ble regulowanych \u015brodowiskach i stosujemy t\u0119 wiedz\u0119 specjalistyczn\u0105 w sektorach farmaceutycznym, biotechnologicznym i badawczym.<\/p>\n

Wnosi bogate do\u015bwiadczenie w zakresie strategii, transformacji, innowacji, zarz\u0105dzania i przyw\u00f3dztwa operacyjnego. Rebecca do\u0142\u0105cza do Vanguard po siedmiu latach pracy w Specsavers Group, w tym ponad czterech latach na stanowisku Dyrektora Zarz\u0105dzaj\u0105cego Newmedica, gdzie kierowa\u0142a rozwojem i rozwojem jednego z wiod\u0105cych brytyjskich dostawc\u00f3w specjalistycznej opieki okulistycznej.<\/p>\n

Rebecca ma r\u00f3wnie\u017c do\u015bwiadczenie zdobyte na stanowiskach kierowniczych w firmach Specsavers i ASDA, a wcze\u015bniej pracowa\u0142a w KPMG.<\/p>\n

Wspieranie kolejnego etapu Vanguard Life Sciences<\/h2>\n

Uruchomiona w 2026 r. sp\u00f3\u0142ka Vanguard Life Sciences rozszerza kompetencje Grupy w zakresie nowoczesnych metod budowlanych w zakresie zaawansowanych \u015brodowisk czystych pomieszcze\u0144, laboratori\u00f3w i zabezpiecze\u0144.<\/p>\n

Wsp\u00f3\u0142pracuj\u0105c z organizacjami z sektora farmaceutycznego, biotechnologicznego i badawczego, Vanguard Life Sciences zapewnia specjalistyczn\u0105 infrastruktur\u0119 zaprojektowan\u0105 tak, aby spe\u0142nia\u0107 wymagania z\u0142o\u017conych i regulowanych \u015brodowisk, k\u0142ad\u0105c nacisk na jako\u015b\u0107, szybko\u015b\u0107 i elastyczno\u015b\u0107.<\/p>\n

Rebecca powiedzia\u0142a:<\/p>\n

\n

\u201cVanguard Life Sciences to wyj\u0105tkowa okazja, aby wykorzysta\u0107 wiedz\u0119 specjalistyczn\u0105, kt\u00f3r\u0105 Vanguard budowa\u0142o przez ponad dwie dekady, i zastosowa\u0107 j\u0105 w innym, silnie regulowanym \u015brodowisku, w kt\u00f3rym jako\u015b\u0107, szybko\u015b\u0107 i elastyczno\u015b\u0107 maj\u0105 ogromne znaczenie\u201d.\u201d<\/p>\n<\/blockquote>\n

Jako dyrektor generalny grupy Rebecca b\u0119dzie kierowa\u0107 Vanguard Life Sciences wraz z Rozwi\u0105zania Vanguard dla opieki zdrowotnej<\/a> i mi\u0119dzynarodowych operacji opieki zdrowotnej Grupy poprzez Rozwi\u0105zania Q-bital dla opieki zdrowotnej<\/a>.<\/p>\n

Jej nominacja zbiega si\u0119 z umacnianiem pozycji firmy Vanguard Life Sciences w sektorze i opracowywaniem rozwi\u0105za\u0144 \u0142\u0105cz\u0105cych specjalistyczn\u0105 wiedz\u0119 techniczn\u0105 z zaletami nowoczesnych metod budowy.<\/p>\n

M\u00f3wi\u0105c o szerszych mo\u017cliwo\u015bciach dla Grupy, Rebecca doda\u0142a:<\/p>\n

\n

\u201cIstnieje znaczny potencja\u0142 wykraczaj\u0105cy poza nasz\u0105 ugruntowan\u0105 pozycj\u0119 w brytyjskiej bran\u017cy opieki zdrowotnej. Jestem podekscytowany ci\u0105g\u0142ym rozwojem Q-bital na arenie mi\u0119dzynarodowej i szans\u0105, jak\u0105 stwarza nam Vanguard Life Sciences, aby wykorzysta\u0107 nasze do\u015bwiadczenie w z\u0142o\u017conych, regulowanych \u015brodowiskach na nowym rynku\u201d.\u201d<\/p>\n<\/blockquote>\n

Dr Graham Rich, przewodnicz\u0105cy Vanguard Healthcare Solutions, powiedzia\u0142:<\/p>\n

\n

\u201cRebecca wnosi wyj\u0105tkowe po\u0142\u0105czenie kompetencji lidera w opiece zdrowotnej, zdolno\u015bci strategicznych i do\u015bwiadczenia w rozwijaniu wysokiej jako\u015bci us\u0142ug klinicznych.<\/p>\n

\u201cZ przyjemno\u015bci\u0105 witam Rebecc\u0119 w roli koordynatora firmy w kolejnej fazie rozwoju\u201d.\u201d<\/p>\n<\/blockquote>\n

Z przyjemno\u015bci\u0105 witamy Rebecc\u0119 w Grupie Vanguard i z niecierpliwo\u015bci\u0105 czekamy na kolejny rozdzia\u0142 w historii Vanguard Life Sciences, w kt\u00f3rym b\u0119dziemy rozwija\u0107 nasze mo\u017cliwo\u015bci i partnerstwa w sektorach farmaceutycznym, biotechnologicznym i badawczym.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"

Firma Vanguard Life Sciences z przyjemno\u015bci\u0105 wita Rebecc\u0119 Lythe na stanowisku Dyrektora Generalnego Grupy Vanguard. Obejmie ona to stanowisko od 1 wrze\u015bnia 2026 r.<\/p>","protected":false},"author":11,"featured_media":8825,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8824","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nVanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/\" \/>\n<meta property=\"og:locale\" content=\"pl_PL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences\" \/>\n<meta property=\"og:description\" content=\"Vanguard Life Sciences is delighted to welcome Rebecca Lythe as Chief Executive Officer of the Vanguard Group, as she takes up the role from 1 September 2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Vanguard Life Sciences\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T08:44:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-01T08:44:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"chrissybligh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napisane przez\" \/>\n\t<meta name=\"twitter:data1\" content=\"chrissybligh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Szacowany czas czytania\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuty\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\"},\"author\":{\"name\":\"chrissybligh\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#\\\/schema\\\/person\\\/a7817235898449de836f9c0de1c782d5\"},\"headline\":\"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer\",\"datePublished\":\"2026-09-01T08:44:13+00:00\",\"dateModified\":\"2026-09-01T08:44:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\"},\"wordCount\":406,\"image\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/09\\\/Rebecca-L-Headshot-VLS.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"pl-PL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\",\"name\":\"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/09\\\/Rebecca-L-Headshot-VLS.png\",\"datePublished\":\"2026-09-01T08:44:13+00:00\",\"dateModified\":\"2026-09-01T08:44:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#\\\/schema\\\/person\\\/a7817235898449de836f9c0de1c782d5\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#breadcrumb\"},\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/09\\\/Rebecca-L-Headshot-VLS.png\",\"contentUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/09\\\/Rebecca-L-Headshot-VLS.png\",\"width\":1200,\"height\":1200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#website\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/\",\"name\":\"Vanguard Life Sciences\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pl-PL\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#\\\/schema\\\/person\\\/a7817235898449de836f9c0de1c782d5\",\"name\":\"chrissybligh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g\",\"caption\":\"chrissybligh\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","og_locale":"pl_PL","og_type":"article","og_title":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences","og_description":"Vanguard Life Sciences is delighted to welcome Rebecca Lythe as Chief Executive Officer of the Vanguard Group, as she takes up the role from 1 September 2026.","og_url":"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","og_site_name":"Vanguard Life Sciences","article_published_time":"2026-09-01T08:44:13+00:00","article_modified_time":"2026-09-01T08:44:32+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","type":"image\/png"}],"author":"chrissybligh","twitter_card":"summary_large_image","twitter_misc":{"Napisane przez":"chrissybligh","Szacowany czas czytania":"2 minuty"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#article","isPartOf":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/"},"author":{"name":"chrissybligh","@id":"https:\/\/www.vanguardlifesciences.co.uk\/#\/schema\/person\/a7817235898449de836f9c0de1c782d5"},"headline":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer","datePublished":"2026-09-01T08:44:13+00:00","dateModified":"2026-09-01T08:44:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/"},"wordCount":406,"image":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","articleSection":["Uncategorized"],"inLanguage":"pl-PL"},{"@type":"WebPage","@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","url":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","name":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences","isPartOf":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#primaryimage"},"image":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","datePublished":"2026-09-01T08:44:13+00:00","dateModified":"2026-09-01T08:44:32+00:00","author":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/#\/schema\/person\/a7817235898449de836f9c0de1c782d5"},"breadcrumb":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#breadcrumb"},"inLanguage":"pl-PL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/"]}]},{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#primaryimage","url":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","contentUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","width":1200,"height":1200},{"@type":"BreadcrumbList","@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vanguardlifesciences.co.uk\/"},{"@type":"ListItem","position":2,"name":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer"}]},{"@type":"WebSite","@id":"https:\/\/www.vanguardlifesciences.co.uk\/#website","url":"https:\/\/www.vanguardlifesciences.co.uk\/","name":"Vanguard Nauki o \u017cyciu","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vanguardlifesciences.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pl-PL"},{"@type":"Person","@id":"https:\/\/www.vanguardlifesciences.co.uk\/#\/schema\/person\/a7817235898449de836f9c0de1c782d5","name":"chrissybligh","image":{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/secure.gravatar.com\/avatar\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g","caption":"chrissybligh"}}]}},"_links":{"self":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/wp-json\/wp\/v2\/posts\/8824","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/wp-json\/wp\/v2\/comments?post=8824"}],"version-history":[{"count":2,"href":"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/wp-json\/wp\/v2\/posts\/8824\/revisions"}],"predecessor-version":[{"id":8827,"href":"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/wp-json\/wp\/v2\/posts\/8824\/revisions\/8827"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/wp-json\/wp\/v2\/media\/8825"}],"wp:attachment":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/wp-json\/wp\/v2\/media?parent=8824"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/wp-json\/wp\/v2\/categories?post=8824"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/pl_pl\/wp-json\/wp\/v2\/tags?post=8824"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}